Key Metrics
CiteScore 

6.7
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
Scite Index 

0.87 5-Year SI

SJR 

Q3Oncology

SNIP 

1.21
Recommended pre-submission checks
Powered by 

Topics Covered on Cancer Medicine
Cancer Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2300 | GBP 1950 | USD 3025 |
| Publication Time | 19 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Cancer Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Cancer Medicine
Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two\u2010Sample Mendelian Randomization Study
- 1 Oct 2026
- Cancer Medicine
Correction to \u201cImmune\u2010Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)\u201d
- 1 Oct 2026
- Cancer Medicine
Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL\u20102 Inhibitors
- 1 Oct 2026
- Cancer Medicine
Integrated scRNA\u2010Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer\u2010Associated Fibroblast\u2013Dominant Domains in Colorectal Cancer
- 1 Oct 2026
- Cancer Medicine
Combined Active Bone Marrow\u2010Sparing Radiotherapy and Prophylactic PEG\u2010rhG\u2010CSF to Reduce Severe Neutropenia During Platinum\u2010Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
- 1 Oct 2026
- Cancer Medicine
Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
- 1 Oct 2026
- Cancer medicine
Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two\u2010Sample Mendelian Randomization Study
- 1 Oct 2026
- Cancer Medicine
Correction to \u201cImmune\u2010Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)\u201d
- 1 Oct 2026
- Cancer Medicine
Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL\u20102 Inhibitors
- 1 Oct 2026
- Cancer Medicine
Integrated scRNA\u2010Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer\u2010Associated Fibroblast\u2013Dominant Domains in Colorectal Cancer
- 1 Oct 2026
- Cancer Medicine
Combined Active Bone Marrow\u2010Sparing Radiotherapy and Prophylactic PEG\u2010rhG\u2010CSF to Reduce Severe Neutropenia During Platinum\u2010Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
- 1 Oct 2026
- Cancer Medicine
Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
- 1 Oct 2026
- Cancer medicine